Fidelity Investments’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$452M Sell
7,702,746
-61,103
-0.8% -$2.56M 0.02% 596
2026
Q1
$250M Buy
7,763,849
+2,025,640
+35% +$75M 0.01% 770
2025
Q4
$242M Sell
5,738,209
-1,057,488
-16% -$42.6M 0.01% 787
2025
Q3
$233M Sell
6,795,697
-1,312,085
-16% -$37.6M 0.01% 780
2025
Q2
$219M Buy
8,107,782
+1,007,331
+14% +$29.2M 0.01% 780
2025
Q1
$211M Buy
7,100,451
+5,017,728
+241% +$191M 0.01% 778
2024
Q4
$82.5M Buy
2,082,723
+2,016,746
+3,057% +$76.4M ﹤0.01% 1190
2024
Q3
$2.25M Buy
65,977
+16,536
+33% +$465K ﹤0.01% 2364
2024
Q2
$1.07M Buy
49,441
+37,703
+321% +$793K ﹤0.01% 2500
2024
Q1
$260K Sell
11,738
-600
-5% -$14.6K ﹤0.01% 2941
2023
Q4
$339K Buy
12,338
+590
+5% +$14.2K ﹤0.01% 2787
2023
Q3
$262K Buy
11,748
+1,242
+12% +$31.9K ﹤0.01% 2803
2023
Q2
$268K Sell
10,506
-36,176
-77% -$877K ﹤0.01% 2861
2023
Q1
$1.04M Buy
46,682
+294
+0.6% +$7.11K ﹤0.01% 2516
2022
Q4
$1.1M Sell
46,388
-291
-0.6% -$6.76K ﹤0.01% 2514
2022
Q3
$775K Buy
46,679
+9,232
+25% +$208K ﹤0.01% 2667
2022
Q2
$745K Buy
37,447
+11,321
+43% +$229K ﹤0.01% 2744
2022
Q1
$720K Sell
26,126
-48,806
-65% -$1.4M ﹤0.01% 2872
2021
Q4
$3.09M Sell
74,932
-101,416
-58% -$4.48M ﹤0.01% 2471
2021
Q3
$8.19M Sell
176,348
-217,520
-55% -$9.49M ﹤0.01% 2194
2021
Q2
$15.7M Buy
393,868
+1,646
+0.4% +$70.4K ﹤0.01% 1932
2021
Q1
$21.1M Sell
392,222
-344,886
-47% -$19.9M ﹤0.01% 1786
2020
Q4
$36.1M Buy
737,108
+62,734
+9% +$2.91M ﹤0.01% 1458
2020
Q3
$21.9M Buy
674,374
+668,530
+11,440% +$21.2M ﹤0.01% 1524
2020
Q2
$151K Buy
5,844
+672
+13% +$16.7K ﹤0.01% 2662
2020
Q1
$126K Buy
5,172
+2,259
+78% +$56.9K ﹤0.01% 2640
2019
Q4
$82K Buy
+2,913
New +$75.4K ﹤0.01% 2799

Other funds holding VCYT

Fidelity Investments's VCYT Position: Q2 2026 in Review

Fidelity Investments reduced its Veracyte (VCYT) stake by 0.79% in Q2 2026, selling an estimated $2.56M and leaving 7,702,746 shares worth $452M. The position accounts for 0.02% of the portfolio, ranked #596.

Fidelity Investments first reported a position in VCYT in Q4 2019 and has held it in 27 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Fidelity Investments held 7,702,746 shares of Veracyte worth $452M as of Q2 2026.
  • Fidelity Investments sold 61,103 Veracyte shares in Q2 2026, an estimated $2.56M.
  • Veracyte made up 0.02% of Fidelity Investments's portfolio in Q2 2026, its #596 holding.
  • Fidelity Investments first reported a position in Veracyte in Q4 2019 and has held it in 27 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.